News

In the News

In partnership with our network partners, together, we have shared research on real-world treatment patterns in breast and non-small cell lung cancer.

Hero News

09/30/2021

Black, low-income patients with cancer at highest risk for severe COVID-19 complications

By Chris Burkhardt

Patients with cancer demonstrated increased risk for severe COVID-19 complications and mortality, according to study results published in Cancer Reports.

Read

09/30/2021

Black and Low-Income Individuals With Cancer May Be at a Higher Risk for COVID-19 Complications

By Chris Burkhardt

Black and low-income patients with cancer were found to be at a higher risk of having severe complications after being diagnosed with COVID-19, according to findings from a retrospective observational cohort study that was published in Cancer Reports.

Read

09/29/2021

Real-World Data: How Clear Is Your Picture?

By Antoinette Cummins

When it comes to getting a clear picture from real-world data, breadth of view and careful analysis matter equally.

Read

Load more

Press Releases

07/22/2021

Study of Cancer Patients and COVID-19 Highlights Health Disparities

By Antoinette Cummins

This press release was issued by Henry Ford Health System, a member of the Syapse Learning Health Network. DETROIT (July 22, 2021) – Findings from a study led by researchers at Henry Ford Cancer Institute, in collaboration with Advocate Aurora Health, the Food and Drug Administration and Syapse®, show an elevated risk for severe COVID-19 effects o…

Read

06/03/2021

Syapse Announces New Real-World Data Studies Published at 2021 American Society for Clinical Oncology Annual Meeting

By Antoinette Cummins

San Francisco, CA - June 3, 2021 - Syapse®, a leading real-word evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real world care, today announced the publication of five abstracts at the American Society for Clinical Oncology (ASCO) 2021 Annual Meeting, being held virtually June 4 – 8. Each study util…

Read

05/19/2021

Leading Real-World Data and Analytics Organizations Form Industry Coalition to Advance Policies to Support Regulatory Use of Real-World Evidence

By Antoinette Cummins

Washington, D.C.(May 19, 2021) – Five real-world data (RWD) and analytics organizations today announced an industry coalition dedicated to advancing the use of real-world evidence (RWE) to support regulatory decisions. Founding members of the RWE Alliance are Aetion, Flatiron Health, IQVIA, Syapse, and Tempus. The RWE Alliance intends to en…

Read

Load more

Events

Webinar

2021 Syapse Precision Medicine Council: Keynote Sessions

October 24, 2021

Every year, Syapse hosts leaders in real-world evidence and precision medicine across the Syapse Learning Health Network of health system, life science, and regulatory partners and has historically been an invite-only meeting for members of the Syapse Learning Health Network. This year, we are expanding the keynote sessions to any health system, life science, lab, or regulator interested in attending! You can also reach out to events@syapse.com if you are interested in learning more about the full meeting.

Conference

Syapse x HLTH 2021: Join us!

October 24, 2021

Meet us at HLTH 2021! Visit our kiosk (K-548) to learn how the Syapse Insight Analytics Platform can transform your disparate, fragmented real-world data into actionable insights. We recommend booking a 15-minute meeting with a member of our team (see event link below)! On Monday, October 18 at 6:40pm EST we will be hosting a 10-minute Tech Talk in Hall A. Divya Harjani, SD of Business Development at Syapse will walk through key considerations for evaluating your RWE, and how high quality RWD is the cornerstone of RWE you can trust.

Webinar

Leveraging RWE to Empower a Health System's Oncology Precision Medicine Program

September 15, 2021

Two of three leading health system executives place investment in precision medicine as a strategic priority, according to a recent study by the Health Management Academy. Prior to the COVID-19 pandemic, the broader industry — life sciences, commercial labs, and the FDA — was accelerating development and approval of new testing technologies and targeted therapies. The pandemic further demonstrated the promise and the challenges of precision sequencing and necessitated urgent innovations in trial design and real-world evidence. In this webinar, leaders from Advocate Aurora Health will distill best practices from their Oncology Precision Medicine program and discuss the role of real-world data in driving impact on patient care.

Let's chat.

If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.